Detalhe da pesquisa
1.
Production and Characterization of Peptide Antibodies to the C-Terminal of Frameshifted Calreticulin Associated with Myeloproliferative Diseases.
Int J Mol Sci
; 23(12)2022 Jun 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35743246
2.
Evidence of immune elimination, immuno-editing and immune escape in patients with hematological cancer.
Cancer Immunol Immunother
; 69(2): 315-324, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31915854
3.
Impact of peptide:HLA complex stability for the identification of SARS-CoV-2-specific CD8+T cells.
Front Immunol
; 14: 1151659, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37275886
4.
Pre-existing TGF-ß-specific T-cell immunity in patients with pancreatic cancer predicts survival after checkpoint inhibitors combined with radiotherapy.
J Immunother Cancer
; 11(3)2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36948507
5.
Revisiting Circulating Extracellular Matrix Fragments as Disease Markers in Myelofibrosis and Related Neoplasms.
Cancers (Basel)
; 15(17)2023 Aug 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37686599
6.
Therapeutic cancer vaccination against mutant calreticulin in myeloproliferative neoplasms induces expansion of specific T cells in the periphery but specific T cells fail to enrich in the bone marrow.
Front Immunol
; 14: 1240678, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37662956
7.
Validation of a Novel EUS-FNB-Derived Organoid Co-Culture System for Drug Screening in Patients with Pancreatic Cancer.
Cancers (Basel)
; 15(14)2023 Jul 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37509338
8.
An arginase1- and PD-L1-derived peptide-based vaccine for myeloproliferative neoplasms: A first-in-man clinical trial.
Front Immunol
; 14: 1117466, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36911725
9.
First in man study: Bcl-Xl_42-CAF®09b vaccines in patients with locally advanced prostate cancer.
Front Immunol
; 14: 1122977, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36999039
10.
Patients With Myeloproliferative Neoplasms Harbor High Frequencies of CD8 T Cell-Platelet Aggregates Associated With T Cell Suppression.
Front Immunol
; 13: 866610, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35603202
11.
Corrigendum: Patients with myeloproliferative neoplasms harbor high frequencies of CD8 T cell-platelet aggregates associated with T cell suppression.
Front Immunol
; 13: 970322, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35990670
12.
TGFß-derived immune modulatory vaccine: targeting the immunosuppressive and fibrotic tumor microenvironment in a murine model of pancreatic cancer.
J Immunother Cancer
; 10(12)2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36600556
13.
Arginase-2-specific cytotoxic T cells specifically recognize functional regulatory T cells.
J Immunother Cancer
; 10(10)2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-36316062
14.
Anti-PD-L1/PD-L2 therapeutic vaccination in untreated chronic lymphocytic leukemia patients with unmutated IgHV.
Front Oncol
; 12: 1023015, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36483037
15.
Cytotoxic T cells isolated from healthy donors and cancer patients kill TGFß-expressing cancer cells in a TGFß-dependent manner.
Cell Mol Immunol
; 18(2): 415-426, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33408343
16.
A phase 1/2 trial of an immune-modulatory vaccine against IDO/PD-L1 in combination with nivolumab in metastatic melanoma.
Nat Med
; 27(12): 2212-2223, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34887574
17.
Therapeutic Cancer Vaccination With a Peptide Derived From the Calreticulin Exon 9 Mutations Induces Strong Cellular Immune Responses in Patients With CALR-Mutant Chronic Myeloproliferative Neoplasms.
Front Oncol
; 11: 637420, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33718228
18.
Healthy Donors Harbor Memory T Cell Responses to RAS Neo-Antigens.
Cancers (Basel)
; 12(10)2020 Oct 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-33086698
19.
Cancer Immune Therapy for Philadelphia Chromosome-Negative Chronic Myeloproliferative Neoplasms.
Cancers (Basel)
; 12(7)2020 Jul 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32630667
20.
The metabolic enzyme arginase-2 is a potential target for novel immune modulatory vaccines.
Oncoimmunology
; 9(1): 1771142, 2020 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32923127